Mardi Gomberg-Maitland, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Acceleron(SIGNIFICANT), United Therapeutics(SIGNIFICANT), Aerami(MODEST), Keros(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Medtronic(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Intellia- employee(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Aerovate(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Janssen Pharmaceuticals, Inc (Actelion)(MODEST)

View Full Disclosure